Explorer les evidences

0,4 risk_ratioIn the study-level meta-analysis, treatment was associated with a reduction in clinical malaria with a risk ratio of 0.40.

Malipaludismepublié 2020The Lancet. Global healtheurope_pmcdocument de 6 observationsDOI 10.1016/s2214-109x(20)30325-9

66 %The efficacy of L9LS against Plasmodium falciparum infection, as compared with placebo, was 66% with the 150-mg dose.

Malipaludismepublié 2024The New England journal of medicineeurope_pmcdocument de 7 observations

113 per_1000_person-yearsThere were 113 events of uncomplicated clinical malaria per 1000 person-years at risk in the combination group.

Malipaludismepublié 2021The New England journal of medicineeurope_pmcdocument de 10 observations

11,18 %The prevalence of sickle cell trait (HbAS) among 3648 newborns in Mali was 11.18%.

Malitrait drépanocytaireobservé April–August 2021HAL · Unilimdocument de 103 observations

5 foldAnti-AMA-1 antibodies increased significantly in both malaria vaccine groups, peaking at nearly 5-fold higher than baseline in the half-dose group.

Malipaludismepublié 2008PloS oneeurope_pmcdocument de 2 observations

0,02 %La prévalence des gamétocytes chez les enfants de moins d’un an était de 0,020 %.

MalipaludismeHAL · Unilimdocument de 214 observations

21 %Entre 2016 et 2019, le nombre de décès associés au paludisme au Mali a diminué de 21 %, passant de 0,76 à 0,59 décès pour 1000 habitants.

Malipaludismeobservé 2016 à 2019HAL · Unilimdocument de 214 observations

16 joursUne période pré-patente de 16 jours, considérée comme la plus courte, a été signalée pour une souche ouest-africaine de P. malariae.

MalipaludismeHAL · Unilimdocument de 214 observations

50 %Non-falciparum species were primarily detected in adolescents (10–14 years) with frequencies above 50%.

Malinon-falciparum Plasmodium speciespublié 2023Tropical medicine and infectious diseaseeurope_pmcdocument de 16 observations

Le paludisme au Mali est saisonnier avec un pic d'incidence des cas cliniques et de mortalité entre septembre et novembre.

Malipaludismeobservé septembre–novembreHAL · Unilimdocument de 214 observations

7,32 %Dans le dépistage actif, la prévalence du paludisme était de 7,32 % chez les enfants âgés de 10 à 14 ans.

MalipaludismeHAL · Unilimdocument de 214 observations

15 odds_ratioThe odds ratio for greater susceptibility to severe malaria in heterozygous G6PD (A−) females with sickle cell trait was 15.

MaliG6PD (A−) deficiency · paludisme · trait drépanocytairepublié 2011American Journal of HematologyOpenAlexdocument de 9 observationsDOI 10.1002/ajh.22093

97,8 %A randomized, phase 3 study comparing artemether-lumefantrine (AL) Dispersible to crushed AL tablets in 899 African children reported a PCR-corrected cure rate of 97.8% at day 28 for AL Dispersible.

Malipaludismepublié 2015Antimicrobial agents and chemotherapyeurope_pmcdocument de 3 observations

229 000 000 casEn 2019, le nombre de cas de paludisme s'élevait à 229 millions de cas détectés.

Malipaludismeobservé 2019HAL · Unilimdocument de 214 observations

92,1 %In Mali, a retrospective study conducted at CHU Gabriel Touré in Bamako between 2014 and 2018 showed a reduction in cerebral malaria frequency from 92.1% to 83.5% after SMC introduction.

Malipaludismeobservé 2014–2018HAL · Unilimdocument de 147 observations

9 941 patientsBetween July 2022 and October 2023, a total of 9941 patients with severe respiratory illness were enrolled, of whom 588 (5.9%) tested positive for SARS-CoV-2.

Kenya · MaliCOVID-19observé July 2022 to October 2023publié 2026VaccinePubMeddocument de 8 observations

79,8 %The parasite positivity rate decreased from 79.8% on day 1 to 9.5% on day 2 for artemether-lumefantrine.

Malipaludismepublié 2018Malaria journaleurope_pmcdocument de 4 observations

5 000 nouveau-nésAu Mali, le criblage néonatal estime le nombre de naissances d’enfants drépanocytaires entre 5 000 et 6 000 par an.

MalidrépanocytoseHAL · Unilimdocument de 202 observations

2 mg/LA synthetic aminosterol derivative (ASD) showed in vitro activity against dermatophytes with minimum inhibitory concentrations (MICs) ranging from 2 to 8 mg/L.

Malidermatophyte infectionspublié 2013Medical mycologyeurope_pmcdocument de 2 observations

70 %A pilot study conducted in the central region of Segou found IRS reduced malaria incidence by 70%.

MalipaludismeHAL · Unilimdocument de 111 observations

For the artesunate-amodiaquine and artesunate-sulfadoxine/pyrimethamine arms, gametocyte carriage increased on Day 3 and remained constant until Day 7 before decreasing afterward.

Maligametocyte carriage · paludismeobservé 2005–2007publié 2018African journal of laboratory medicineeurope_pmcdocument de 2 observations

30 %In Mali, the model estimate of ONNV prevalence is 30%.

MaliO'nyong-nyong viruspublié 2021Nature communicationseurope_pmcdocument de 6 observations

Parasite densities during disease episodes were lower in the sulfadoxine-pyrimethamine group.

Malipaludismepublié 2002The American journal of tropical medicine and hygieneeurope_pmcdocument de 4 observationsDOI 10.4269/ajtmh.2002.67.604

0,8 %P. ovale a une prévalence allant de 0,8 % à 5 % en Afrique subsahélienne.

MalipaludismeHAL · Unilimdocument de 214 observations

27 %Of the 300 children, 82 (27%) had at least one episode of asymptomatic Plasmodium parasitemia.

Malipaludismepublié 2025New microbes and new infectionseurope_pmcdocument de 2 observations